Atlanta Consulting Group Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$657K Buy
5,421
+160
+3% +$18.5K 0.14% 81
2025
Q4
$557K Buy
5,261
+14
+0.3% +$1.31K 0.13% 86
2025
Q3
$445K Sell
5,247
-119
-2% -$9.8K 0.11% 88
2025
Q2
$429K Sell
5,366
-3,930
-42% -$312K 0.12% 80
2025
Q1
$842K Sell
9,296
-1,434
-13% -$134K 0.25% 51
2024
Q4
$1.07M Buy
10,730
+258
+2% +$26.6K 0.39% 43
2024
Q3
$1.19M Buy
10,472
+440
+4% +$52.3K 0.3% 67
2024
Q2
$1.24M Sell
10,032
-50
-0.5% -$6.44K 0.27% 39
2024
Q1
$1.33M Buy
+10,082
New +$1.24M 0.46% 35

Other funds holding MRK

Atlanta Consulting Group Advisors's MRK Position: Q1 2026 in Review

Atlanta Consulting Group Advisors increased its Merck (MRK) stake by 3% in Q1 2026, buying an estimated $18.5K and bringing the position to 5,421 shares worth $657K. The position accounts for 0.14% of the portfolio, ranked #81.

Atlanta Consulting Group Advisors first reported a position in MRK in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.33M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Atlanta Consulting Group Advisors held 5,421 shares of Merck worth $657K as of Q1 2026.
  • Atlanta Consulting Group Advisors bought 160 Merck shares in Q1 2026, an estimated $18.5K.
  • Merck made up 0.14% of Atlanta Consulting Group Advisors's portfolio in Q1 2026, its #81 holding.
  • Atlanta Consulting Group Advisors first reported a position in Merck in Q1 2024 and has held it in 9 quarters since.
  • Atlanta Consulting Group Advisors's Merck position peaked at $1.33M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Atlanta Consulting Group Advisors's 13F filing for Q1 2026, filed 15 May 2026.